(Q34072096)

English

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

chemoradiotherapy

0 references

pancreatic carcinoma

1 reference

based on heuristic

inferred from title

0 references

author name string

Erkan Topkan

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Cem Parlak

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ayşe Kotek

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ali Fuat Yapar

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Berrin Pehlivan

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

10 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

BMC Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

123

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

10 November 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

Image-Guided Stereotactic Radiosurgery for Locally Advanced Pancreatic Adenocarcinoma Results of First 85 Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

The role of positron emission tomography in the management of pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

Meta-analysis: the detection of pancreatic malignancy with positron emission tomography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

PET imaging in assessing gastrointestinal tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

A tabulated summary of the FDG PET literature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

A combined PET/CT scanner for clinical oncology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

5 July 2018

The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-123

21 January 2018

Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-123

21 January 2018

Non-small cell lung cancer: dual-modality PET/CT in preoperative staging

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-123

21 January 2018

Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-123

21 January 2018

18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-123

21 January 2018

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-123

21 January 2018

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-123

21 January 2018

Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-123

21 January 2018

Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

28 October 2018

Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

28 October 2018

18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224773

28 October 2018

Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved prognostic value of standardized uptake value corrected for blood glucose level in pancreatic cancer using F-18 FDG PET

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FDG-PET evaluation of indeterminate pancreatic masses

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined imaging techniques for pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Gastrointestinal Tumor Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent chemoradiotherapy for advanced pancreatic cancer: 1,000 mg/m2 gemcitabine can be administered using limited-field radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Staging Hodgkin's Disease with 18-FDG PET Comparison with CT and Surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074002

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-230X-11-123

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34072096&oldid=2196202671"